Effect of Breathwalk on body composition, metabolic and mood state in chronic hepatitis C patients with insulin resistance syndrome.

AIM To identify the anthropometric, metabolic and mood state in hepatitis C virus (HCV)-infected patients from the west of Mexico and to evaluate the effect of Breathwalk (BW), a combination of walking, synchronized breathing and focussed attention, on those patients. METHODS In an experimental study, 17 patients with serological and molecular diagnosis of HCV, not receiving pharmacological treatment, were studied. One hour sessions of BW were practiced 3 times at week for six months. Body composition was assessed by electric impedance. Biochemical profiles and insulin resistance (IR) risk was assessed by conventional methods. Mood state was evaluated with specific and open questions at the beginning and at the end of the program. RESULTS Seventy percent of patients were overweight or obese, and 77% of the patients presented with IR at the beginning of the study. Improvements were observed at the 3rd mo, and statistically significant differences were recorded at the 6th mo using the fitness score (76 vs 83, P < 0.01), in alanine aminotransferase (ALT) (106 +/- 93 U/L vs 59 +/- 32 U/L, P < 0.01), total bilirubin (0.09 +/- 1 mg/dL vs 0.62 +/- 0.2 mg/dL, P < 0.01), ALT/AST ratio (1.04 vs 0.70, P < 0.01), triglycerides (165 +/- 86 mg/dL vs 124 +/- 49 mg/dL, P < 0.01) and the IR risk (4.0 vs 2.7). Most patients (88%) indicated to feel better at the end of BW (P < 0.01). CONCLUSION Breathwalk has an important effect on body composition, lipid profile and liver enzymes. It is also easy, inexpensive and has a beneficial effect on metabolic and mood state in HCV patients.

[1]  Stefan Sleijfer,et al.  Side Effects of Interferon-α Therapy , 2005, Pharmacy World and Science.

[2]  W. Kraus,et al.  Effects of the amount and intensity of exercise on plasma lipoproteins. , 2002, The New England journal of medicine.

[3]  Usefulness of plasma glucose and insulin concentrations in identifying patients with insulin resistance. , 2003, The American journal of cardiology.

[4]  M. Splaine,et al.  Use of the Reliable Change Index to evaluate clinical significance in SF-36 outcomes , 2002, Quality of Life Research.

[5]  A. Panduro,et al.  Low Prevalence of Anti-Hepatitis C Virus Antibodies in Mexico: A Systematic Review , 2006, Intervirology.

[6]  B. Vergès,et al.  Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. , 2001, Journal of hepatology.

[7]  J. Kench,et al.  Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression , 2003 .

[8]  J. Després,et al.  Exercise in weight management of obesity. , 2001, Cardiology clinics.

[9]  G. Fricchione,et al.  Functional brain mapping of the relaxation response and meditation , 2000, Neuroreport.

[10]  F. Işitan,et al.  Insulin resistance in chronic hepatitis C , 2004, International journal of clinical practice.

[11]  A. Panduro,et al.  Identification of hepatitis C virus (HCV) genotypes in infected patients from the west of Mexico , 1998 .

[12]  S. Weinman,et al.  Hepatitis C: a metabolic liver disease. , 2004, Gastroenterology.

[13]  R. Uauy,et al.  Obesity in Developing Countries : Biological and Ecological Factors Obesity Trends in Latin America : Transiting from Under-to Overweight 1 , 2001 .

[14]  P. Chou,et al.  Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study. , 2007, American journal of epidemiology.

[15]  G. Tomlinson,et al.  High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C , 2003, Hepatology.

[16]  H. Tildesley,et al.  Effective exercise modality to reduce insulin resistance in women with type 2 diabetes. , 2003, Diabetes care.

[17]  E. Strauss,et al.  Quality of life in hepatitis C , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[18]  H. Florez,et al.  Women relatives of Hispanic patients with type 2 diabetes are more prone to exhibit metabolic disturbances. , 1999, Investigacion clinica.

[19]  R. Ross,et al.  Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. , 2004, Obesity research.

[20]  Tracey McLaughlin,et al.  Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant , 2003, Annals of Internal Medicine.

[21]  L. Seeff,et al.  Aasld Practice Guideline Diagnosis, Management, and Treatment of Hepatitis C , 2003 .

[22]  M. Richardson,et al.  Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1 , 2005, Gut.

[23]  D. Purdie,et al.  Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C , 2002, Gut.

[24]  R. Ross,et al.  Exercise without weight loss is an effective strategy for obesity reduction in obese individuals with and without Type 2 diabetes. , 2005, Journal of applied physiology.

[25]  H. Lukaski,et al.  Body composition assessment of athletes using bioelectrical impedance measurements. , 1990, The Journal of sports medicine and physical fitness.

[26]  R. Eckel,et al.  Exercise training, without weight loss, increases insulin sensitivity and postheparin plasma lipase activity in previously sedentary adults. , 2003, Diabetes care.

[27]  K. Segal,et al.  Use of bioelectrical impedance analysis measurements as an evaluation for participating in sports. , 1996, The American journal of clinical nutrition.

[28]  W. Kraus,et al.  Studies of a targeted risk reduction intervention through defined exercise (STRRIDE). , 2001, Medicine and science in sports and exercise.

[29]  K. Koike Hepatitis C Virus Infection Can Present with Metabolic Disease by Inducing Insulin Resistance , 2005, Intervirology.

[30]  G. Choudhuri,et al.  Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis , 2006, Journal of gastroenterology and hepatology.

[31]  A. Zekry,et al.  Insulin resistance and steatosis in hepatitis C virus infection , 2005, Gut.

[32]  Luis Durán-Arenas,et al.  Hacia una base normativa mexicana en la medición de calidad de vida relacionada con la salud, mediante el Formato Corto 36 , 2004 .

[33]  N. Ruderman,et al.  Insulin resistance in type 2 diabetes: association with truncal obesity, impaired fitness, and atypical malonyl coenzyme A regulation. , 2003, The Journal of clinical endocrinology and metabolism.

[34]  G. Alexander,et al.  Association of diabetes mellitus and chronic hepatitis C virus infection , 1999, Hepatology.

[35]  Ryoichi Narita,et al.  Insulin resistance and insulin secretion in chronic hepatitis C virus infection. , 2004, Journal of hepatology.